title: Efinaconazole 10% nail solution: a post-FDA approval update.
authors.forename: Aditya K
authors.initials: AK
authors.lastname: Gupta
authors.forename: Fiona C
authors.initials: FC
authors.lastname: Simpson
authors.forename: William
authors.initials: W
authors.lastname: Abramovits
authors.forename: Noah
authors.initials: N
authors.lastname: Scheinfeld
mesh_terms: D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D009262:Nails / Q000473:pathology; D014009:Onychomycosis / Q000188:drug therapy*; D019999:Pharmaceutical Solutions; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000935:Antifungal Agents; D019999:Pharmaceutical Solutions; D014230:Triazoles; C431707:efinaconazole